Why the Choice of Score Matters
At an interim analysis, a continuous outcome gives each arm an estimated mean, but the means alone do not determine what “best-performing” means. A mean difference measures estimated benefit in the outcome’s original units. A standardized effect expresses that difference relative to a stated variability scale. A precision-adjusted score also accounts for sample size and uncertainty. These scores answer different questions, so choosing among them is part of specifying the selection rule—not a cosmetic calculation.
This tutorial concerns selection scores for comparing experimental arms with a concurrent control. A score ranks arms for a continuation decision; by itself, it does not establish efficacy, control a type I error rate, or account for the consequences of selection in later testing.
Model, Direction, and Notation
Let arm \(0\) denote control and arm \(i\) an experimental arm. At the interim look, let \(n_i\), \(\bar{x}_i\), and \(s_i\) be the observed sample size, sample mean, and sample standard deviation for arm \(i\), including \(i=0\). Assume independent participants across arms, a common outcome definition and measurement time, and independent observations within each arm. For the usual standard-error calculations, assume finite variances; normal outcomes make the Welch comparison exact in its numerator and approximate in its studentized distribution.
Orient the outcome so that larger values are better. If smaller values are better, reverse the sign of the outcome or of every contrast consistently. The estimated treatment-control difference is \( \hat{\Delta}_i = \bar{x}_i-\bar{x}_0 \). A positive value then favors experimental arm \(i\). The direction must be set before comparing scores, not chosen after seeing which sign makes an arm look favorable.
For example, a 3-point difference on a symptom scale is directly interpretable as a difference in scale points. Dividing it by a standard deviation gives a unitless effect size. Dividing it by a standard error instead gives a signal-to-noise statistic that depends on both variability and sample size.
Three Useful Score Constructions
The most transparent starting point is the unstandardized difference \( \hat{\Delta}_i \). It is often suitable when the outcome scale is clinically meaningful and the selection objective is to retain arms with the largest estimated benefit in those units. If arms have different interim sample sizes or outcome variances, the raw differences still describe estimated benefit, but they do not describe how precisely each benefit has been estimated.
A standardized effect requires a reference scale. One option is a prespecified external standard deviation \(s_{\mathrm{ref}}\); another is the control-arm standard deviation \(s_0\). For the latter, the score is \( \hat{\Delta}_i/s_0 \), sometimes called a control-SD-standardized difference. It answers how large the estimated benefit is relative to control-arm outcome variability. When using an estimated \(s_0\), the score itself also has sampling uncertainty; it is a descriptive selection score, not an exact test statistic.
For an evidence-oriented score under unequal variances, use the Welch standard error:
The score \(W_i\) is dimensionless and increases when the estimated benefit is large relative to its estimated sampling uncertainty. With normal observations and known variances, the analogous standardized difference has a standard normal distribution under a zero mean difference. With estimated variances, the Welch statistic is commonly assessed using a \(t\) approximation and Welch–Satterthwaite degrees of freedom; for selection, it may instead be used as a ranking score without interpreting it as a hypothesis test.
A standardized effect and a precision-adjusted score are not interchangeable. Standardizing by a typical outcome SD emphasizes magnitude relative to outcome variation; dividing by the standard error emphasizes evidence relative to estimation uncertainty. Sample size enters the latter directly, but not the former.
Why the Unequal-Variance Standard Error Works
For independent arm samples, the estimated difference is the difference of two sample means. Its variance is the sum of their variances: the variance of a sample mean in arm \(i\) is \( \sigma_i^2/n_i \), and the control mean contributes \( \sigma_0^2/n_0 \). Thus \( \operatorname{Var}(\bar{X}_i-\bar{X}_0)=\sigma_i^2/n_i+\sigma_0^2/n_0 \). Replacing the unknown variances with \(s_i^2\) and \(s_0^2\) yields the Welch standard error above.
This calculation does not assume equal within-arm variances. By contrast, a pooled-variance standard error assumes a common variance and can misstate precision when that assumption is poor, especially when arm sizes and variances differ. If the trial has a shared control, the estimated contrasts are correlated with one another because each uses \(\bar{x}_0\); separate arm scores remain calculable, but their rankings are not statistically independent.
Worked Example: Ranking by Difference and Standardized Effect
Suppose a hypothetical trial measures improvement on a scale where larger values are better. At an interim look, control has mean 4.0 points and standard deviation 2.0 points. Experimental arm A has mean 6.2 points, and arm B has mean 5.8 points. Compare mean-difference scores and control-SD-standardized effects.
For arm A, \( \hat{\Delta}_A=6.2-4.0=2.2 \) points. For arm B, \( \hat{\Delta}_B=5.8-4.0=1.8 \) points. Ranking by estimated benefit in scale points places A above B, since \(2.2>1.8\).
Using the observed control SD as the reference, the standardized scores are \(2.2/2.0=1.10\) for A and \(1.8/2.0=0.900\) for B. The ranking remains A above B. The interpretation is that the estimated benefits are respectively 1.10 and 0.900 control-arm standard deviations; it is not a statement about the probability of benefit or statistical significance.
Worked Example: Unequal Variability Changes the Precision Ranking
Consider hypothetical continuous outcomes with larger values better. At the interim analysis, control has \(n_0=40\), mean 10.0 units, and SD 4.0 units. Arm A has \(n_A=30\), mean 13.0, and SD 8.0. Arm B has \(n_B=30\), mean 12.5, and SD 2.0. Calculate raw differences, control-SD-standardized effects, and Welch precision-adjusted scores.
The mean differences are \( \hat{\Delta}_A=13.0-10.0=3.0 \) units and \( \hat{\Delta}_B=12.5-10.0=2.5 \) units. Thus A has the larger estimated benefit in the original outcome units.
The control-SD-standardized effects are \(3.0/4.0=0.750\) for A and \(2.5/4.0=0.625\) for B. This scale-based ranking also favors A.
For A, the unequal-variance standard error is \(SE_A=\sqrt{8.0^2/30+4.0^2/40}=\sqrt{64/30+16/40}=\sqrt{2.533}=1.591\) units. Therefore \(W_A=3.0/1.591=1.886\).
For B, \(SE_B=\sqrt{2.0^2/30+4.0^2/40}=\sqrt{4/30+16/40}=\sqrt{0.5333}=0.7303\) units, giving \(W_B=2.5/0.7303=3.423\). The precision-adjusted ranking favors B, because B’s much smaller observed variability gives a more precise estimated difference. The calculation does not make B’s estimated benefit larger: it shows that ranking by precision-adjusted evidence answers a different question from ranking by effect magnitude.
Worked Example: Applying a Clinical Threshold Before Ranking
Suppose a hypothetical continuous endpoint is measured in millimetres, with larger improvement better. The clinical-relevance threshold established for the decision is 5 mm. At an interim analysis, control has mean improvement 20 mm and SD 10 mm; arm C has mean 26 mm and arm D has mean 25.5 mm. Compare their estimated benefits with the threshold and express the effects relative to control variability.
The estimated differences are \( \hat{\Delta}_C=26-20=6.0 \) mm and \( \hat{\Delta}_D=25.5-20=5.5 \) mm. Both exceed the 5 mm threshold by their point estimates: C by \(6.0-5.0=1.0\) mm, and D by \(5.5-5.0=0.5\) mm. Ranking their point estimates places C first.
The control-SD-standardized effects are \(6.0/10=0.600\) for C and \(5.5/10=0.550\) for D. Because they share the same reference SD, the effect-size ranking is also C above D. This comparison does not show that either arm’s true effect exceeds 5 mm with a specified degree of confidence; that would require an uncertainty-based rule. The point-estimate comparison is only the stated selection score.
Diagnostics, Alternatives, and Limitations
Before applying a score, check that its inputs and interpretation match the decision:
- Verify the direction and units. A sign error can reverse the selected arm. Report raw differences with outcome units and label the standardized scale as unitless.
- Inspect arm-specific variability and sample size. A large SD or small \(n_i\) can make an arm’s estimated difference uncertain. Unequal variability is a reason not to substitute a pooled-variance standard error without justification.
- State the standardization reference. A control SD, a prespecified external SD, and a pooled SD define different effect-size scales. Do not report a standardized effect without naming its denominator.
- Check whether the score matches the aim. If the aim is to retain the largest estimated clinical benefit, rank mean differences. If the aim is to prioritize evidence relative to sampling error, a precision-adjusted score may be appropriate. If the aim is to retain clinically worthwhile arms, compare with the clinical threshold as specified by the selection rule.
- Consider shared-control dependence. Since each treatment-control contrast uses the same control mean, noise in that mean shifts all contrasts together. A close ranking should not be treated as independent confirmation that one arm is superior.
The main alternative is to rank arms by a confidence-bound score, which incorporates both estimated effect and uncertainty in a chosen direction. That can be useful when the selection rule explicitly values conservative evidence, but it is not the same as ranking by observed mean difference or standardized effect. The earlier material on confidence-bound selection rules provides that framework. A clinical threshold can also be incorporated by comparing each estimated difference with the threshold, but a point-estimate excess should not be described as certain clinical benefit.
Selection scores have further limits. Interim means and SDs can be unstable with small samples, and an extreme early estimate may regress toward the underlying effect as information accrues. A score also does not correct for outcome missingness, data-quality problems, or multiple looks, and it does not guarantee that the arm selected is truly best. These issues require design and operational choices beyond the arithmetic of a score.
Common Pitfall
Correction: A larger estimated difference means a larger observed benefit in the outcome’s units, not necessarily a more precise estimate. In the unequal-variability example, A had the larger difference, while B had the larger Welch score. State which selection objective is being used, then apply that score consistently. Neither ranking alone proves that an arm is effective.
Check Your Understanding
Answer each question, then compare with the solutions below.
- Control mean is 12 units and an experimental-arm mean is 15 units, with larger values better. What is the treatment-control mean-difference score, including its direction?
- If the control SD is 5 units, what is the control-SD-standardized effect for the difference in question 1?
- Why can the arm with the smaller raw difference have the larger Welch precision-adjusted score?
- When is a pooled-variance standard error inappropriate for an interim comparison?
Solutions. (1) The score is \(15-12=3\) units, favoring the experimental arm. (2) The standardized effect is \(3/5=0.600\), or 0.600 control SDs. (3) The smaller difference can have a smaller standard error—such as from lower variability or a larger sample—and therefore a larger ratio of difference to standard error. (4) It is inappropriate when the common within-arm variance assumption is not justified; with unequal variances, use the Welch standard error \( \sqrt{s_i^2/n_i+s_0^2/n_0} \) for a precision-adjusted comparison.